Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
03/2010
03/25/2010WO2010013078A3 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
03/25/2010US20100076192 PROCESS FOR PRODUCING 5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-c]PYRIDINE-2-CARBOXYLIC ACID
03/25/2010US20100076036 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
03/24/2010EP2164847A1 3-aza-bicyclo[3.3.0]octane compounds
03/24/2010CN101679457A Piperazine and [1,4] diazepan derivatives as NK antagonists
03/24/2010CN101679456A Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
03/24/2010CN101679455A New progesterone receptor modulators
03/24/2010CN101679304A Pyridazine-, pyridine- and pyrane-derivatives as GPBAR1 agonisis
03/24/2010CN101679279A Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/23/2010US7683070 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide
03/23/2010US7683056 Pyridine derivatives and their use in the treatment of psychotic disorders
03/18/2010WO2010031054A1 Compositions and methods for treating epilepsy
03/18/2010WO2010030954A1 Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
03/18/2010WO2010029461A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/18/2010US20100069378 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
03/18/2010US20100069374 Tricyclic benzopyrane compound
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010CA2736130A1 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
03/18/2010CA2735184A1 Heteroaryls amide derivatives and their use as glucokinase activators
03/17/2010EP2162445A1 Heterobicyclic compounds as kinase inhibitors
03/17/2010EP2162132A1 Heterocyclic kinase modulators
03/17/2010CN101675045A Hetarylanilines as modulators for amyloid beta
03/16/2010US7678910 Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]Pyridine-2-carboxylic acid
03/16/2010US7678909 Dipeptidyl peptidase inhibitors
03/16/2010US7678813 8a-Benzyl-2-(4-methoxyphenyl)-1,3,4,7,8,8a-hexahydro-2H-isoquinolin-6-one; psychotic major depression, schizoaffective disorder, Alzheimer's Disease and cocaine addiction
03/16/2010US7678783 Inhibits the activity of beta -secretase or BACE, thus preventing the formation of insoluble A beta and arresting the production of A beta
03/11/2010WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors
03/11/2010WO2009026446A9 Hdac inhibitors
03/11/2010US20100063277 Intramolecular C-H amination with sulfonyl azides
03/11/2010US20100063035 Carbonic anhydrase inhibitors derivatives
03/11/2010US20100063027 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/11/2010CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors
03/11/2010CA2733533A1 Hedgehog pathway modulators
03/10/2010EP2160393A1 Novel compounds as cannabinoid receptor ligands
03/10/2010CN101665501A Method for preparing talipexole
03/09/2010US7674796 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010US20100056510 Macrocyclic Compound
03/04/2010US20100056502 Compounds
03/03/2010EP2158207A1 Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
03/03/2010EP1541575B1 Novel process for producing imidazo(1,2-b)pyridazine derivative
03/02/2010US7671078 1,3-dicyclohexyl-2-(5,6-dihydro-imidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; 1,3-dicycloheptyl-2-(6,6-dimethyl-5,6-dihydroimidazo[2,1-b]thiazol-3-ylmethyl)-isothiourea; CXC chemokine Receptor
03/02/2010US7671068 N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
02/2010
02/25/2010WO2009152356A3 Compounds and compositions useful for the treatment of malaria
02/25/2010US20100048555 Imidazothiazole derivatives as mark inhibitors
02/25/2010US20100047172 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
02/24/2010EP2155740A1 Hetarylanilines as modulators for amyloid beta
02/24/2010EP1625121B1 Pyrimidine derivatives for the treatment of abnormal cell growth
02/24/2010CN101654459A Pyrrole [2, 1-b] thiazolium compound and preparation method and anti-tumor application thereof
02/23/2010US7666879 enzyme inhibitor; 2-{2-Fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide; angiogenesis inhibitor; antitumor agent; treating hyperglycemia, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, autoimmune diseases, inflammation, and eye disorders
02/23/2010US7666876 Buprenorphine formulations for intranasal delivery
02/23/2010US7666869 Nitrogen-containing 5-membered ring compound
02/18/2010WO2009117728A3 Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
02/18/2010US20100041660 Novel 2-pyridinecarboxamide derivatives
02/18/2010US20100041656 Novel amide derivatives and medicinal use thereof
02/17/2010EP2152719A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/17/2010EP1828200B1 Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer's disease.
02/17/2010CN101648962A C3/C3 fluoroquinolone dipolymer derivative taking s-triazolo-[3,4-b][1,3,4] thiadiazole as connecting chain and preparation method and application thereof
02/16/2010CA2478183C Substituted amides
02/16/2010CA2225822C Nitroimidazole antibacterial compounds and methods of use thereof
02/11/2010WO2010017093A2 Dopamine receptor ligands with enhanced duration of action
02/11/2010WO2010016005A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
02/11/2010WO2010015520A1 Substituted naphthyridines and use thereof as medicines
02/11/2010CA2732087A1 Substituted naphthyridines and their use as medicaments
02/11/2010CA2731368A1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
02/10/2010EP2151440A1 Heterocyclic compound and use thereof
02/10/2010EP2150251A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/09/2010US7659401 Thiazolo[4,5-C]pyridine derivatives
02/09/2010US7659399 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents
02/09/2010US7659284 Thiazolopyridine kinase inhibitors
02/09/2010US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders
02/09/2010CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
02/09/2010CA2274201C Di-or triaza-spiro[4,5]decane derivatives
02/04/2010WO2010014930A2 Therapeutic agents
02/04/2010WO2010014611A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
02/04/2010WO2010013794A1 Spiroaminodihydrothiazine derivatives
02/04/2010WO2010013302A1 Spiroaminodihydrothiazine derivative
02/04/2010WO2010013078A2 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
02/04/2010WO2010012345A1 Imidazothiadiazoles derivatives
02/04/2010US20100029731 Method for preparing largazole analogs and uses thereof
02/04/2010US20100029632 improved pharmacokinetics
02/04/2010US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives
02/04/2010US20100029611 Sphingosine-1-phosphate (S1P) receptor modulating agents such as 1-((3-fluoro-4-(5(1-phenylcyclopropyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)methyl)azetidine-3-carboxylic acid, used for the treatment of autoimmune diseases; side effect reduction
02/04/2010US20100029041 Organic semiconductor material and organic electronic device
02/04/2010CA2732631A1 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
02/04/2010CA2732628A1 Therapeutic agents
02/04/2010CA2732186A1 Imidazothiadiazole derivatives
02/04/2010CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
02/04/2010CA2731209A1 Spiroaminodihydrothiazine derivatives
02/03/2010EP2148858A1 Inhibitors of iap
02/02/2010US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
02/02/2010US7655676 Selective activity against propionibacterium acne; minimum inhibitory concentration (MIC) against Propionibacterium acnes strains both sensitive and resistant to erythromycin and clindamycin and against a series Staphylococcus strains
02/02/2010US7655650 Oxadiazine derivatives
02/02/2010US7655648 Antibacterial agents
02/02/2010CA2507923C Tetracyclic 3-substituted indoles having serotonin receptor affinity
01/2010
01/28/2010WO2010011964A2 Imaging agents useful for identifying ad pathology
01/28/2010WO2010010435A2 Fused oxazole and thiazole derivatives as trpms modulators
01/28/2010WO2009107850A3 Fused heterocyclic derivative and use thereof
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 152